Gerald B. Wertheim, MD, PhD Gerald B. Wertheim, MD, PhD, is a pathologist with the Hematopathology Laboratory at Children's Hospital of Philadelphia. Locations: Main Campus Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467) Education and Training Medical SchoolMD, PhD - University of Pennsylvania School of Medicine, Philadelphia, PA ResidencyAnatomic and Clinical Pathology - Hospital of the University of Pennsylvania, Philadelphia, PA FellowshipHematopathology - Hospital of the University of Pennsylvania, Philadelphia, PA Board CertificationAmerican Board of Pathology, HematopathologyAmerican Board of Pathology/Anatomic PathologyUndergraduate DegreeBS in Chemistry - Yale University, New Haven, CT Titles and Academic Titles Pathologist Departments and Services Hematopathology Division of Anatomic PathologyDivision of Genomic Diagnostics Publications Papers2014 Choi, SM, Papenhausen P, Wertheim G, and King RL: Near-haploid B lymphoblastic leukemia with an apparent hyperdiploid karyotype: the critical role of SNP analysis in establishing proper diagnosis. Journal Of Hematopathology 2014. Gerhardt DM, Pajcini KV, D'altri T, Tu L, Jain R, Xu L, Chen M, Rentschler S, Shestova O, Wertheim GB, Tobias J, Kluk M, Wood AW, Aster JC, Gimotty PA, Epstein JA, Speck N, Bigas A, Pear WS : The Notch1 transcriptional activation domain is required for development and reveals a novel role for Notch1 signaling in fetal hematopoietic stem cells. Genes and Development 2014. Luskin M*, Wertheim G*, Morrissette J, Daber R, Biegel J, Wilmoth D, Kersun L, King R, Paessler M, Simon C, Aplenc R and Loren A*. Authors contributed equally: CLL/SLL diagnosed in an adolescent. Pediatric Blood & Cancer 2014. O'Brien S, Rajan MT, Wertheim G, Wells A: Ikaros imposes a barrier to CD8+ T cell differentiation by restricting autocrine IL-2 production. Journal of Immunology 2014. Raess, PW, van de Geijn GJM, Njo TL, Klop B, Sukhachev D, Wertheim G, McAleer T, Master SR, Bagg A.: Automated screening for myelodysplastic syndromes through analysis of complete blood count and cell population data parameters. American Journal of Hematology 2014. Wertheim, GBW, Smith, C, Figueroa, ME, Kalos, M, Bagg, A, Carroll M, and Master, SR: Microsphere-based Multiplex Analysis of DNA Methylation in Acute Myeloid Leukemia. Journal of Mol. Diagnostics 2014. 2012 Wertheim Gerald BW, Daber R, Bagg A: Molecular Diagnostics of Acute Myeloid Leukemia: It's a (Next) Generational Thing. The Journal of molecular diagnostics : JMD Nov 2012. Wertheim GBW, Hexner E, Bagg A: Molecular-Based Classification of Acute Myeloid Leukemia and Its Role in Directing Rational Therapy: Personalized Medicine for Profoundly Promiscuous Proliferations. Molecular diagnosis & therapy Nov 2012. Abstracts2013 King RL, Paessler ME, Wertheim GB: AML with monosomy 7 and features of transformed JMML. 11th Annual International Workshop on Bone Marrow Pathology. Munich, Germany. September 2013. King RL, Wertheim GB, Paessler ME: Pure red cell aplasia with progression to hypocellular MDS in a child. 11th Annual International Workshop on Bone Marrow Pathology. Munich, Germany. September 2013. King RL, Wertheim GB, Paessler ME: Pure red cell aplasia with progression to hypocellular MDS in a child. 11th Annual International Workshop on Bone Marrow Pathology. Munich, Germany. September 2013. King RL, Paessler MP, Wertheim GB: Incidental EBV-Positivity in Pediatric Post-Transplant Patients and Tonsillectomy Specimens Demonstrates the Need for Stringent Criteria for Diagnosing PTLD. Society for Pediatric Pathology Annual Meeting, Baltimore, MD. 2013. King RL, Wertheim GB, Papenhausen P, Choi SM: Near-haploid B lymphoblastic leukemia with an apparent hyperdiploid karyotype. Society for Hematopathology Workshop, Houston, TX. 2013. King RL, Wertheim GB, Papenhausen P, Choi SM: T lymphoblastic leukemia with t(5;14)(q35;q32) with lineage switch to acute myeloid leukemia. Society for Hematopathology Workshop, Houston, TX. 2013. 2012 Frank, R, Wertheim, G, Kamoun, M, and Lal, P: Cardiac Allograft Outcomes: A Retrospective Study Correlating DSA, Endomyocardial Biopsy and Immunofluorescence. USCAP Annual Meeting 2012. Wertehim, G: Immunoglobulin Light Chain Detection in FFPE Tissue Atlantic Regional Hematopatholgy Meeting, Fox Chase Cancer Center, Philadelphia, PA 2012. Wertehim, G: A Novel Assay of DNA Methylation for Classification of Acute Myeloid Leukemia" International Society of Laboratory Hematology Annual Meeting, Nice, France 2012. BooksChapters Wertheim GB, Bagg A: Minimal residual disease testing to predict relapse following transplant for AML and high-grade myelodysplastic syndromes. Expert review of molecular diagnostics 11(4): 361-6, May 2011. Awards and Honors 2012, International Society of Laboratory Hematology; One Top Five Abstracts at Society's International Meeting; Nice, France. 2005, Endocrinology Research Award, University of Pennsylvania School of Medicine 1996, The Stella Botelho Award in Physiology, University of Pennsylvania School of Medicine 1995-2005, 21st Century/Gamble Scholarship (Full Four-Year Medical School Tuition), University of Pennsylvania School of Medicine 1994, The Werner Bergmann Award in Chemistry, Yale University 1993, Phi Beta Kappa, Yale University Editorial and Academic Positions Editorial positions 2011-present, Journal of Molecular Diagnostics, Ad Hoc Reviewer 2011-present, Cancer Genetics, Ad Hoc Reviewer Academic and institutional committees 2013-present, Hematopathology Faculty Search Committee, Member 2013-present, Pediatric Hematopathology Faculty Search Committee, Member 2013-present, Hematopathology Director Search Committee, Member Patient Experience Ratings About the Patient Experience Rating System The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question. Responses are measured on a scale of 1 to 5 with 5 being the best score. We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments. Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care. The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.